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The outstanding role of EGFR
A high proportion of human tumor cells is characterized by over-
expression of epidermal growth factor receptor (EGFR), a protein that
promotes resistance to chemo- and radiotherapy. 1-5 EGFR protein can
be activated through phosphorylation at specific amino acid residues
in response to ligand binding (EGF, TGF alpha and Amphiregulin)
as well as after exposure to a variety of unspecific stimuli like ion-
izing radiation, UV-radiation, hypoxia, hyperthermia, oxidative stress
and trans-activation by G-protein coupled receptors.6-13 Both ligand-
dependent as well as ligand-independent phosphorylations of EGFR
result in receptor internalization and intracellular signalling.4,5,14-17 Up
to date internalization is assumed to be essential for receptor silenc-
ing and inactivation. Indeed, EGF treatment results in internaliza-
tion of EGFR into coated pits followed by receptor degradation.18
Exposure to oxidative stress can lead to internalization of EGFR into
caveolae, however this process is associated with peri-nuclear accu-
mulation of EGFR and persistent kinase activity, as reported by
Khan.12 The broad inducibility of EGFR activation and internalization
by cellular stress, suggest an essential role of EGFR during regula-
tion of cellular survival. The special role of nuclear EGFR has been
underlined by the clinical observations, that detection of nuclear EGFR
in tumors biopsies is strongly correlated with treatment resistance and
bad prognosis.1,19-22
Radiation induced internalization of EGFR
A characteristic compound of caveolae is the protein caveolin.
Caveolin gene family consists of three members: CAV1, CAV2, and
CAV3, coding for the proteins caveolin-1, caveolin-2 and caveolin-3,
respectively. Caveolins associate with cholesterol and sphingolipids
in specific areas of the cell membrane to form caveolae. Caveolae
are involved in receptor independent endocytosis and intracellular
signalling.23 In addition, caveolin-1 is a transmembrane protein and
an essential component during interactions of integrin receptors with
cytoskeleton-associated molecules.24 Caveolae contain a high vari-
ety of proteins essential for signalling. Caveolae and associated pro-
teins form the so called caveosome which can fuse with the early
endosomes.25 Moreover, caveolin-1 is found at many intracellular
locations. Variations in subcellular localization are paralleled by a
plethora of ascribed functions for this protein. These observations
suggest a general function of caveolae as an intracellular signalling
platform. In agreement with that, compartmentation into caveolae
prevents EGFR degradation and simultaneously enables intracellu-
lar EGFR kinase linked signalling.12 These findings suggest a new
function of EGFR – depending on its intracellular localization –,
which supplements its functions described so far. Ionizing radiation
results in fast src kinase stabilization, activation and subsequent src
mediated caveolin-1 Y14- and EGFR Y845-phosphorylations. Both
phosphorylations are radiation specific and can not be observed after
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Emerging evidence suggests the existence of a new mode of epidermal growth factor receptor (EGFR) signalling in which activated EGFR
undergoes nuclear translocation. We provide evidence that the nuclear EGFR transport is a stress specific cellular reaction, which is linked to
src dependent EGFR internalization into caveolae. Internalized EGFR is sorted into a peri-nuclear localization. This peri-nuclear EGFR may
serve as a reservoir for nuclear transport which is regulated by PKC ±. Nuclear EGFR induces transcription of genes essential for cell prolifera-
tion and cell cycle regulation. In addition, nuclear EGFR has physical contact with compounds of the DNA repair machinery and is involved in
removal of DNA-damage. The exact role of nuclear EGFR has to be elucidated in future experiments.
ACTA MEDICA NAGASAKIENSIA 53: 55－59, 2008
Keywords: Radiation; Nuclear EGFR; DNA-repair
Klaus H. Dittmann et al.: Nuclear EGFR is Linked with DNA-Repair
treatment with EGF, which suggests caveolae-sorting of EGFR as a
stress-associated event.26 Inhibition of EGFR by the antibody Erbitux
results in a strong accumulation of caveolin/EGFR complexes within
the cytoplasm, which can not be further increased by irradiation.
Radiation-induced caveolin-1- and EGFR-phosphorylations are associ-
ated with nuclear EGFR transport.26,27 As shown by the specific inhibi-
tor PP2, blockage of src activity inhibits caveolin-1-phosphorylation
and decreased nuclear transport of EGFR.26
Translocation of EGFR from caveolae into
endoplasmatic reticulum (ER)
Nuclear localization of the EGF receptor requires endocytosis
and association of the receptor with the karyopherin carrier nuclear
import system.27 However, this association does not explain how a
transmembrane receptor is processed into a nuclear non-membrane-
bound receptor. As cells do have protein complexes that translocate
proteins into and out of lipid bilayers, Liao et al. explored the pos-
sibility, that the Sec61 translocon could mediate nuclear transport
of the EGF receptor.27-29 EGFR located within the membrane of late
endosomes is transferred to the membranes of Golgi apparatus by
membrane fusion and at least locates in the ER membrane. For nu-
clear transport EGFR has to be set free from ER-membrane to be-
come a cytosolic protein and to admit access of the karyopherin sys-
tem to the intrinsic nuclear localization site of the EGFR. The Sec61
translocon is located exclusively in the endoplasmic reticulum (ER)
and ER/Golgi transitional region and functions to insert secretory and
transmembrane proteins into the ER during protein synthesis.30,31
The translocon is bidirectional and retrotranslocates also proteins from
ER membrane to the cytosol.
EGFR transport into nucleus
Passage through the nuclear pore complex (NPC) needs binding
to nuclear transport receptors. Many proteins are imported via
karyopherin-ß (often using karyopherin-á as an adaptor). Indeed it
was shown, that after irradiation the EGFR is found in complex with
karyopherin-á and RAN-GTP.5 Prerequisite for karyopherin-binding
is the presence of a nuclear localization site (NLS) within the cargo
protein. Classic NLSs contain one or two clusters of basic residues.
Monopartite NLSs, exemplified by the SV40 large-T antigen, have
a single cluster of 4–5 basic residues, whereas bipartite NLSs, such
as that of nucleoplasmin, have a second basic cluster located ~10–
12 residues downstream of the first cluster.32 Molecular recognition
of NLSs is essential for the formation of the import complex. Lin
et al.33 reported identification of a putative NLS within the EGFR
sequence and proved the function. Interestingly, we observed
phoshorylation of EGFR at residue T654, which is located within
this putative EGFR NLS, after radiation-induced nuclear EGFR
transport. Furthermore, we identified PKC ± as the kinase respon-
sible for this modification.34 So far it is not resolved whether this
phosphorylation regulates assembly of the EGFR-karyopherin á/ß
transport complex within the cytosol, or disassembly within nucleus.
However, first results with cells expressing EGFR mutated in NLS
(Dittmann et al., unpublished data) argue for a regulative role of
T654 phosphorylation during assembly of transport complex after
radiation. Nuclear EGFR accumulation results from a balance of im-
port and export processes.5 Recent evidence suggest, that nuclear ex-
port of EGFR may involve exportin CRM1. 35 Existence of nuclear
export sequences within EGFR sequence however, has not been dem-
onstrated.
Function of nuclear EGFR
Nuclear EGFR detection was first reported in hepatocytes that un-
derwent regeneration and in primary adrenocortical carcinomas.36,37
High levels of EGFR were detected in the nuclei of many tumours,
including those of adrenocorticord, breast, bladder, skin, thyroid and
oral cavity. 37,38,39,36,40,22 Nuclear EGFR appears to be the full-length
phosphorylated receptor.5,33,41 Nuclear EGFR positively correlates with
Ki-67, expression, an indicator of proliferation.40 Consequently, a
function of nuclear EGFR as transcriptional activator was suggested.
Indeed, transactivation domains within EGFR, HER-2 and HER-4
were identified and found to be functional.33,42 Nuclear EGFR and
HER-2 were shown to associate with specific DNA sequences des-
ignated AT-rich sequence and HER-2-associated sequence, respec-
tively.33,42 Promoters that are targeted by nuclear EGFR are those of
cyclin D1, iNOS and B-Myb.33,43,44 Given the notion that ErbB re-
ceptors lack a putative DNA-binding domain, it is suspected that
these receptors first associate with DNA-binding transcription fac-
tors and then enhance target gene transcription via their intrinsic
transactivational activity. In this regard, nuclear EGFR interacts with
STAT3 and co-regulates iNOS expression.44 Furthermore coopera-
tion of nuclear EGFR with the transcription factor E2F1 activates
expression of B-Myb, a positive regulator of G1/S cell cycle pro-
gression.43 The observation that nuclear EGFR is phosphorylated at
autophosphorylation sites indicates that kinase activity of EGFR is pre-
sent within nucleus and suggests that this kinase activity may be rele-
vant for the function of nuclear EGFR. Indeed Wang et al. could dem-
onstrate that, PCNA is subject to tyrosine phosphorylation at a specific
site in an EGFR dependent manner and that this phosphorylation en-
hances PCNA stability on the chromatin.45 Thus these data link tyro-
sine kinase activity of nuclear EGFR with cell proliferation and DNA
repair by regulating PCNA function.
In addition, Bandyopadhyay et al. described that nuclear EGFR
can interact with DNA-repair and cell survival directly.46 They de-
scribed physical interaction of EGFR with DNA dependent kinase
(DNA-PK). Furthermore they demonstrated that blocking EGFR
signalling by Erbitux, an anti-EGFR monoclonal antibody, resulted
in reduction of nuclear DNA-PK protein and kinase activity, impli-
cating a role of EGFR in regulation of DNA repair. Indeed it could
be shown that nuclear EGFR is associated with phosphorylation of
DNA-PK at residue T2609, which stands for DNA-PK activity
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during non-homologous end-joining DNA-repair.5 Blockage of nu-
clear EGFR transport by Erbitux decreased DNA-PK activity and
consequently increased residual DNA-damage and reduced survival
after radiation treatment.47 These observations suggest a crucial role
of nuclear EGFR for regulation of DNA-repair following treatment
with genotoxic substances.
Translational Approach
Earlier we could show that either the Bowman Birk proteinase in-
hibitor BBI or its derivate P-Tyr can act as a selective radioprotectors
in normal or tumor cells characterized by a wild type TP53, when
cells are treated prior to irradiation.48-50 It was shown, that for BBI-
mediated radioprotection the activation of DNA-PK activity is es-
sential. Consequently, DNA-repair quality was improved, measured
as reduction of residual dicentric chromosomes.51 These data sug-
gest a clear effect of BBI and P-Tyr upon DNA-repair in general
and presumably on DNA-double strand break repair especially.
However, the molecular mode of action was unknown. Recent re-
sults form our laboratory indicate, that BBI and P-Tyr interfere with
EGFR phosphorylation and radiation-induced EGFR transport into
the cell nucleus.52,53 This transport is involved in regulation of DNA-
PK activity which is essential for DNA-repair.5,54 Thus when given
before irradiation, BBI and P-Tyr both stimulate EGFR nuclear trans-
port and consequently improve radiation-induced DNA-damage and
enhance cellular survival.
Summary
Current knowledge about nuclear transport is summarized in
Figure 1. Nuclear localization of EGFR was observed either after cell
stimulation with EGF or after treatment with genotoxic substances.
However, the scenario described herein in fact is oversimplified,
since the effects of nuclear EGFR are superimposed by the cytosolic
signalling of membrane associated EGFR. In addition, nuclear EGFR
interacts with other members of the erbB-receptor family also de-
tected within the nucleus. Nevertheless the relevance of nuclear EGFR
for cell survival and DNA-repair is beyond doubt and these data may
not only improve our knowledge on basic mechanisms of radiation
sensitivity / resistance, but also will promote new strategies for clini-
cally molecular targeting.
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Figure 1. Role of nuclear EGFR during cellular radiation response
Radiation activates src kinase in a so far not understood manner. Src phosphorylates EGFR at residue residue Y845 and caveolin1 at
residue Y14, which seems to be signal for complex formation and internalization into caveolae. EGFR containing caveolae are transported
to the Golgi / endoplasmatic reticulum (ER) in a microtubule dependent way and fuse with ER membrane. EGFR is found in complex
with translocon Sec61 and set free by its action into the cytosol. EGFR is phosphorylated at residue T654 by means of PKC±, which in-
duces binding of karyopherin á and binding of karyopherin ß. This process enables transport through nuclear pore into nucleus. Karyopherins
dissociate from nuclear complex and are exported to cytosol back. Nuclear EGFR either interacts with DNA-PK and is involved in acti-
vation of kinase activity essential for non-homologous end-joining DNA-repair, or acts as a transcription factor regulating expression of
essential genes.
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